Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials.

Pai RK, Kleiner DE, Hart J, Adeyi OA, Clouston AD, Behling CA, Jain D, Kakar S, Brahmania M, Burgart L, Batts KP, Valasek MA, Torbenson MS, Guindi M, Wang HL, Ajmera V, Adams LA, Parker CE, Feagan BG, Loomba R, Jairath V.

Aliment Pharmacol Ther. 2019 Nov;50(10):1100-1111. doi: 10.1111/apt.15503. Epub 2019 Oct 3.

PMID:
31583739
2.

Practical Application of Lineage-Specific Immunohistochemistry Markers: Transcription Factors (Sometimes) Behaving Badly.

Lou SKS, Adeyi OA.

Arch Pathol Lab Med. 2019 Aug 6. doi: 10.5858/arpa.2019-0226-RA. [Epub ahead of print]

PMID:
31385722
3.

Liver Transplantation for Acute Liver Failure Due to Dengue Fever.

Galante A, Adeyi O, Lau L, Humar A, Galvin Z, Selzner N, Lilly L, Sapisochin G, Bhat M.

Hepatology. 2019 Nov;70(5):1863-1865. doi: 10.1002/hep.30803. Epub 2019 Aug 9. No abstract available.

PMID:
31162847
4.

Predictor parameters of liver viability during porcine normothermic ex situ liver perfusion in a model of liver transplantation with marginal grafts.

Linares-Cervantes I, Echeverri J, Cleland S, Kaths JM, Rosales R, Goto T, Kollmann D, Hamar M, Urbanellis P, Mazilescu L, Ganesh S, Adeyi OA, Yip P, Goryńska P, Bojko B, Goryński K, Grant DR, Selzner N, Wąsowicz M, Selzner M.

Am J Transplant. 2019 Nov;19(11):2991-3005. doi: 10.1111/ajt.15395. Epub 2019 May 28.

PMID:
31012532
5.

Impact of Different Clinical Perfusates During Normothermic Ex Situ Liver Perfusion on Pig Liver Transplant Outcomes in a DCD Model.

Linares-Cervantes I, Kollmann D, Goto T, Echeverri J, Kaths JM, Hamar M, Urbanellis P, Mazilescu L, Rosales R, Bruguera C, Oquendo F, Ganesh S, Adeyi OA, Yip P, Selzner N, Selzner M.

Transplant Direct. 2019 Mar 4;5(4):e437. doi: 10.1097/TXD.0000000000000876. eCollection 2019 Apr.

6.

Gross and microscopic changes of liver neoplasms and background hepatic structures following neoadjuvant therapy.

Hodgson A, Almansouri Z, Adeyi O, Fischer SE.

J Clin Pathol. 2019 Feb;72(2):112-119. doi: 10.1136/jclinpath-2018-205596. Review.

PMID:
30670563
7.

Developing Allogeneic Double-Negative T Cells as a Novel Off-the-Shelf Adoptive Cellular Therapy for Cancer.

Lee JB, Kang H, Fang L, D'Souza C, Adeyi O, Zhang L.

Clin Cancer Res. 2019 Apr 1;25(7):2241-2253. doi: 10.1158/1078-0432.CCR-18-2291. Epub 2019 Jan 7.

PMID:
30617140
8.

Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.

Galvin Z, Rajakumar R, Chen E, Adeyi O, Selzner M, Grant D, Sapisochin G, Greig P, Cattral M, McGilvray I, Ghanekar A, Selzner N, Lilly L, Patel K, Bhat M.

Liver Transpl. 2019 Jan;25(1):56-67. doi: 10.1002/lt.25338.

PMID:
30609189
9.

The Economic Transition of Health in Africa: A Call for Progressive Pragmatism to Shape the Future of Health Financing.

Ly C, Eozenou P, Nandakumar A, Pablos-Mendez A, Evans T, Adeyi O.

Health Syst Reform. 2017 Oct 2;3(4):290-300. doi: 10.1080/23288604.2017.1325549.

PMID:
30359180
10.

Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations.

MacParland SA, Liu JC, Ma XZ, Innes BT, Bartczak AM, Gage BK, Manuel J, Khuu N, Echeverri J, Linares I, Gupta R, Cheng ML, Liu LY, Camat D, Chung SW, Seliga RK, Shao Z, Lee E, Ogawa S, Ogawa M, Wilson MD, Fish JE, Selzner M, Ghanekar A, Grant D, Greig P, Sapisochin G, Selzner N, Winegarden N, Adeyi O, Keller G, Bader GD, McGilvray ID.

Nat Commun. 2018 Oct 22;9(1):4383. doi: 10.1038/s41467-018-06318-7.

11.

Alma-Ata at 40 years: reflections from the Lancet Commission on Investing in Health.

Watkins DA, Yamey G, Schäferhoff M, Adeyi O, Alleyne G, Alwan A, Berkley S, Feachem R, Frenk J, Ghosh G, Goldie SJ, Guo Y, Gupta S, Knaul F, Kruk M, Nugent R, Ogbuoji O, Qi J, Reddy S, Saxenian H, Soucat A, Jamison DT, Summers LH.

Lancet. 2018 Oct 20;392(10156):1434-1460. doi: 10.1016/S0140-6736(18)32389-4. Review. No abstract available.

PMID:
30343859
12.

Quality of Care.

Peabody J, Shimkhada R, Adeyi O, Wang H, Broughton E, Kruk ME.

In: Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R, editors. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 27. Chapter 10.

13.

Universal Health Coverage and Intersectoral Action for Health.

Jamison DT, Alwan A, Mock CN, Nugent R, Watkins DA, Adeyi O, Anand S, Atun R, Bertozzi S, Bhutta Z, Binagwaho A, Black R, blecher M, Bloom BR, Brouwer E, Bundy DAP, Chisholm D, Cieza A, Cullen M, Danforth K, Silva Nd, Debas HT, Donkor P, Dua T, Fleming KA, Gallivan M, Garcia P, Gawande A, Gaziano T, Gelband H, Glass R, Glassman A, Gray G, Habte D, Holmes KK, Horton S, Hutton G, Jha P, Knaul F, Kobusingye O, Krakauer E, Kruk ME, Lachmann P, Laxminarayan R, Levin C, Looi LM, Madhav N, Mahmoud A, Mbanya JC, Measham AR, Medina-Mora ME, Medlin C, Mills A, Mills JA, Montoya J, Norheim O, Olson Z, Omokhodion F, Oppenheim B, Ord T, Patel V, Patton GC, Peabody J, Prabhakaran D, Qi J, Reynolds T, Ruacan S, Sankaranarayanan R, Sepúlveda J, Skolnik R, Smith KR, Temmerman M, Tollman S, Verguet S, Walker D, Walker N, Wu Y, Zhao K.

In: Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R, editors. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 27. Chapter 1.

14.

High-quality health systems in the Sustainable Development Goals era: time for a revolution.

Kruk ME, Gage AD, Arsenault C, Jordan K, Leslie HH, Roder-DeWan S, Adeyi O, Barker P, Daelmans B, Doubova SV, English M, Elorrio EG, Guanais F, Gureje O, Hirschhorn LR, Jiang L, Kelley E, Lemango ET, Liljestrand J, Malata A, Marchant T, Matsoso MP, Meara JG, Mohanan M, Ndiaye Y, Norheim OF, Reddy KS, Rowe AK, Salomon JA, Thapa G, Twum-Danso NAY, Pate M.

Lancet Glob Health. 2018 Nov;6(11):e1196-e1252. doi: 10.1016/S2214-109X(18)30386-3. Epub 2018 Sep 5. Review. No abstract available. Erratum in: Lancet Glob Health. 2018 Sep 18;:. Erratum in: Lancet Glob Health. 2018 Nov;6(11):e1162.

15.

PPAR-gamma activation is associated with reduced liver ischemia-reperfusion injury and altered tissue-resident macrophages polarization in a mouse model.

Linares I, Farrokhi K, Echeverri J, Kaths JM, Kollmann D, Hamar M, Urbanellis P, Ganesh S, Adeyi OA, Yip P, Selzner M, Selzner N.

PLoS One. 2018 Apr 4;13(4):e0195212. doi: 10.1371/journal.pone.0195212. eCollection 2018.

16.

Inhibition of the Fibrinogen-Like Protein 2:FcγRIIB/RIII immunosuppressive pathway enhances antiviral T-cell and B-cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13.

Luft O, Khattar R, Farrokhi K, Ferri D, Yavorska N, Zhang J, Sadozai H, Adeyi O, Chruscinski A, Levy GA, Selzner N.

Immunology. 2018 Jul;154(3):476-489. doi: 10.1111/imm.12897. Epub 2018 Feb 20.

17.

Comparison of BQ123, Epoprostenol, and Verapamil as Vasodilators During Normothermic Ex Vivo Liver Machine Perfusion.

Echeverri J, Goldaracena N, Kaths JM, Linares I, Roizales R, Kollmann D, Hamar M, Urbanellis P, Ganesh S, Adeyi OA, Tazari M, Selzner M, Selzner N.

Transplantation. 2018 Apr;102(4):601-608. doi: 10.1097/TP.0000000000002021.

PMID:
29189484
18.

Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition.

Jamison DT, Alwan A, Mock CN, Nugent R, Watkins D, Adeyi O, Anand S, Atun R, Bertozzi S, Bhutta Z, Binagwaho A, Black R, Blecher M, Bloom BR, Brouwer E, Bundy DAP, Chisholm D, Cieza A, Cullen M, Danforth K, de Silva N, Debas HT, Donkor P, Dua T, Fleming KA, Gallivan M, Garcia PJ, Gawande A, Gaziano T, Gelband H, Glass R, Glassman A, Gray G, Habte D, Holmes KK, Horton S, Hutton G, Jha P, Knaul FM, Kobusingye O, Krakauer EL, Kruk ME, Lachmann P, Laxminarayan R, Levin C, Looi LM, Madhav N, Mahmoud A, Mbanya JC, Measham A, Medina-Mora ME, Medlin C, Mills A, Mills JA, Montoya J, Norheim O, Olson Z, Omokhodion F, Oppenheim B, Ord T, Patel V, Patton GC, Peabody J, Prabhakaran D, Qi J, Reynolds T, Ruacan S, Sankaranarayanan R, Sepúlveda J, Skolnik R, Smith KR, Temmerman M, Tollman S, Verguet S, Walker DG, Walker N, Wu Y, Zhao K.

Lancet. 2018 Mar 17;391(10125):1108-1120. doi: 10.1016/S0140-6736(17)32906-9. Epub 2017 Nov 25. Review.

19.

The Lancet Commission on pollution and health.

Landrigan PJ, Fuller R, Acosta NJR, Adeyi O, Arnold R, Basu NN, Baldé AB, Bertollini R, Bose-O'Reilly S, Boufford JI, Breysse PN, Chiles T, Mahidol C, Coll-Seck AM, Cropper ML, Fobil J, Fuster V, Greenstone M, Haines A, Hanrahan D, Hunter D, Khare M, Krupnick A, Lanphear B, Lohani B, Martin K, Mathiasen KV, McTeer MA, Murray CJL, Ndahimananjara JD, Perera F, Potočnik J, Preker AS, Ramesh J, Rockström J, Salinas C, Samson LD, Sandilya K, Sly PD, Smith KR, Steiner A, Stewart RB, Suk WA, van Schayck OCP, Yadama GN, Yumkella K, Zhong M.

Lancet. 2018 Feb 3;391(10119):462-512. doi: 10.1016/S0140-6736(17)32345-0. Epub 2017 Oct 19. Review. No abstract available. Erratum in: Lancet. 2018 Feb 3;391(10119):430.

PMID:
29056410
20.

Pathology primer: Common liver biopsy findings in patients who have recently undergone liver transplant or resection.

Adeyi OA.

Clin Liver Dis (Hoboken). 2017 Aug 30;10(2):42-48. doi: 10.1002/cld.652. eCollection 2017 Aug. Review. No abstract available.

21.

Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic Syndrome.

Ghazarian M, Revelo XS, Nøhr MK, Luck H, Zeng K, Lei H, Tsai S, Schroer SA, Park YJ, Chng MHY, Shen L, D'Angelo JA, Horton P, Chapman WC, Brockmeier D, Woo M, Engleman EG, Adeyi O, Hirano N, Jin T, Gehring AJ, Winer S, Winer DA.

Sci Immunol. 2017 Apr 21;2(10). pii: eaai7616. doi: 10.1126/sciimmunol.aai7616.

22.

Overexpression of fibrinogen-like protein 2 protects against T cell-induced colitis.

Bartczak A, Zhang J, Adeyi O, Amir A, Grant D, Gorczynski R, Selzner N, Chruscinski A, Levy GA.

World J Gastroenterol. 2017 Apr 21;23(15):2673-2684. doi: 10.3748/wjg.v23.i15.2673.

23.

Health Care Expenditures Associated With Pollution: Exploratory Methods and Findings.

Preker AS, Adeyi OO, Lapetra MG, Simon DC, Keuffel E.

Ann Glob Health. 2016 Sep - Oct;82(5):711-721. doi: 10.1016/j.aogh.2016.12.003.

24.

Anti-inflammatory signaling during ex vivo liver perfusion improves the preservation of pig liver grafts before transplantation.

Goldaracena N, Echeverri J, Spetzler VN, Kaths JM, Barbas AS, Louis KS, Adeyi OA, Grant DR, Selzner N, Selzner M.

Liver Transpl. 2016 Nov;22(11):1573-1583. doi: 10.1002/lt.24603.

25.

Mechanism of hard-nanomaterial clearance by the liver.

Tsoi KM, MacParland SA, Ma XZ, Spetzler VN, Echeverri J, Ouyang B, Fadel SM, Sykes EA, Goldaracena N, Kaths JM, Conneely JB, Alman BA, Selzner M, Ostrowski MA, Adeyi OA, Zilman A, McGilvray ID, Chan WC.

Nat Mater. 2016 Nov;15(11):1212-1221. doi: 10.1038/nmat4718. Epub 2016 Aug 15.

26.

Health System in Nigeria: From Underperformance to Measured Optimism.

Adeyi O.

Health Syst Reform. 2016 Oct 1;2(4):285-289. doi: 10.1080/23288604.2016.1224023. No abstract available.

PMID:
31514723
27.

Thyroid and reproductive hormones disruption as well as kallikrein-3 level in dimethyl nitrosamine-induced toxicity: Effects of ascorbate treatment in male wistar rats.

Somade OT, Ugbaja RN, Adeyi OE, Ogunberu DM.

Biochim Open. 2016 Sep 28;3:40-46. doi: 10.1016/j.biopen.2016.09.002. eCollection 2016 Dec.

28.

Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation.

Doyle A, Adeyi O, Khalili K, Fischer S, Dib M, Goldaracena N, Dillon J, Grant D, Cattral M, McGilvray I, Greig P, Ghanekar A, Lilly L, Renner E, Levy G, Selzner N.

Liver Transpl. 2016 Sep;22(9):1295-300. doi: 10.1002/lt.24495. No abstract available.

29.

2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

Demetris AJ, Bellamy C, Hübscher SG, O'Leary J, Randhawa PS, Feng S, Neil D, Colvin RB, McCaughan G, Fung JJ, Del Bello A, Reinholt FP, Haga H, Adeyi O, Czaja AJ, Schiano T, Fiel MI, Smith ML, Sebagh M, Tanigawa RY, Yilmaz F, Alexander G, Baiocchi L, Balasubramanian M, Batal I, Bhan AK, Bucuvalas J, Cerski CTS, Charlotte F, de Vera ME, ElMonayeri M, Fontes P, Furth EE, Gouw ASH, Hafezi-Bakhtiari S, Hart J, Honsova E, Ismail W, Itoh T, Jhala NC, Khettry U, Klintmalm GB, Knechtle S, Koshiba T, Kozlowski T, Lassman CR, Lerut J, Levitsky J, Licini L, Liotta R, Mazariegos G, Minervini MI, Misdraji J, Mohanakumar T, Mölne J, Nasser I, Neuberger J, O'Neil M, Pappo O, Petrovic L, Ruiz P, Sağol Ö, Sanchez Fueyo A, Sasatomi E, Shaked A, Shiller M, Shimizu T, Sis B, Sonzogni A, Stevenson HL, Thung SN, Tisone G, Tsamandas AC, Wernerson A, Wu T, Zeevi A, Zen Y.

Am J Transplant. 2016 Oct;16(10):2816-2835. doi: 10.1111/ajt.13909. Epub 2016 Jul 14.

30.

XB130 deficiency enhances lipopolysaccharide-induced septic response and acute lung injury.

Toba H, Tomankova T, Wang Y, Bai X, Cho HR, Guan Z, Adeyi OA, Tian F, Keshavjee S, Liu M.

Oncotarget. 2016 May 3;7(18):25420-31. doi: 10.18632/oncotarget.8326.

31.

Overexpression of Fibrinogen-Like Protein 2 Promotes Tolerance in a Fully Mismatched Murine Model of Heart Transplantation.

Bartczak A, Chruscinski A, Mendicino M, Liu H, Zhang J, He W, Amir AZ, Nguyen A, Khattar R, Sadozai H, Lobe CG, Adeyi O, Phillips MJ, Zhang L, Gorczynski RM, Grant D, Levy GA.

Am J Transplant. 2016 Jun;16(6):1739-50. doi: 10.1111/ajt.13696. Epub 2016 Mar 17.

33.

Protease inhibitors partially overcome the interferon nonresponse phenotype in patients with chronic hepatitis C.

Duarte-Rojo A, Fischer SE, Adeyi O, Zita D, Deneke MG, Selzner N, Chen L, Malespin M, Cotler SJ, McGilvray ID, Feld JJ.

J Viral Hepat. 2016 May;23(5):340-7. doi: 10.1111/jvh.12494. Epub 2015 Dec 29.

PMID:
26710754
34.

Subnormothermic ex vivo liver perfusion is a safe alternative to cold static storage for preserving standard criteria grafts.

Spetzler VN, Goldaracena N, Echiverri J, Kaths JM, Louis KS, Adeyi OA, Yip PM, Grant DR, Selzner N, Selzner M.

Liver Transpl. 2016 Jan;22(1):111-9. doi: 10.1002/lt.24340.

35.

Infiltrative (sinusoidal) and hepatitic patterns of injury in acute cellular rejection in liver allograft with clinical implications.

Siddiqui I, Selzner N, Hafezi-Bakhtiari S, Marquez MA, Adeyi OA.

Mod Pathol. 2015 Sep;28(9):1275-81. doi: 10.1038/modpathol.2015.84. Epub 2015 Jul 31.

36.

Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma.

Mason M, Adeyi O, Fung S, Millar BA.

BMJ Case Rep. 2014 Nov 28;2014. pii: bcr2014208117. doi: 10.1136/bcr-2014-208117.

37.

Subnormothermic ex vivo liver perfusion reduces endothelial cell and bile duct injury after donation after cardiac death pig liver transplantation.

Knaak JM, Spetzler VN, Goldaracena N, Boehnert MU, Bazerbachi F, Louis KS, Adeyi OA, Minkovich L, Yip PM, Keshavjee S, Levy GA, Grant DR, Selzner N, Selzner M.

Liver Transpl. 2014 Nov;20(11):1296-305. doi: 10.1002/lt.23986.

38.

The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.

Urbanellis P, Shyu W, Khattar R, Wang J, Zakharova A, He W, Sadozai H, Amir AZ, Shalev I, Phillips MJ, Adeyi O, Ross H, Grant D, Levy GA, Chruscinski A.

Immunology. 2015 Jan;144(1):91-106. doi: 10.1111/imm.12354.

39.

Metabolic syndrome-related hepatocellular carcinoma treated by volumetric modulated arc therapy.

Klein J, Dawson LA, Tran TH, Adeyi O, Purdie T, Sherman M, Brade A.

Curr Oncol. 2014 Apr;21(2):e340-4. doi: 10.3747/co.21.1756.

40.

Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.

Terrault NA, Stravitz RT, Lok AS, Everson GT, Brown RS Jr, Kulik LM, Olthoff KM, Saab S, Adeyi O, Argo CK, Everhart JE, Rodrigo del R; A2ALL Study Group.

Hepatology. 2014 Apr;59(4):1311-9. doi: 10.1002/hep.26920. Epub 2014 Mar 1.

41.

Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE.

Khattar R, Luft O, Yavorska N, Shalev I, Phillips MJ, Adeyi O, Gao D, Bartczak A, Urbanellis P, Shyu W, Zhang J, Manuel J, Levy GA, Selzner N.

PLoS One. 2013 Oct 11;8(10):e72309. doi: 10.1371/journal.pone.0072309. eCollection 2013.

42.

Endothelial cells do not arise from tumor-initiating cells in human hepatocellular carcinoma.

Ghanekar A, Ahmed S, Chen K, Adeyi O.

BMC Cancer. 2013 Oct 20;13:485. doi: 10.1186/1471-2407-13-485.

43.

Generation of subcutaneous and intrahepatic human hepatocellular carcinoma xenografts in immunodeficient mice.

Ahmed SU, Zair M, Chen K, Iu M, He F, Adeyi O, Cleary SP, Ghanekar A.

J Vis Exp. 2013 Sep 25;(79):e50544. doi: 10.3791/50544.

44.

Angiotensin blockade does not affect fibrosis progression in recurrent hepatitis C after liver transplantation.

Guillaud O, Gurram KC, Puglia M, Lilly L, Adeyi O, Renner EL, Selzner N.

Transplant Proc. 2013 Jul-Aug;45(6):2331-6. doi: 10.1016/j.transproceed.2013.01.067.

PMID:
23953545
45.

Common problems in liver allograft biopsy interpretation: Resolving clinical dilemmas.

Adeyi OA.

Clin Liver Dis (Hoboken). 2013 Aug 19;2(4):181-187. doi: 10.1002/cld.229. eCollection 2013 Aug. Review. No abstract available.

46.

Normothermic acellular ex vivo liver perfusion reduces liver and bile duct injury of pig livers retrieved after cardiac death.

Boehnert MU, Yeung JC, Bazerbachi F, Knaak JM, Selzner N, McGilvray ID, Rotstein OD, Adeyi OA, Kandel SM, Rogalla P, Yip PM, Levy GA, Keshavjee S, Grant DR, Selzner M.

Am J Transplant. 2013 Jun;13(6):1441-9. doi: 10.1111/ajt.12224. Epub 2013 May 13.

47.

From discrete monomeric complexes to hydrogen-bonded dimeric assemblies based on sterically encumbered square planar palladium(II) ONN-pincers.

Adeyi O, Cross WB, Forrest G, Godfrey L, Hope EG, McLeod A, Singh A, Singh K, Solan GA, Wang Y, Wright LA.

Dalton Trans. 2013 Jun 7;42(21):7710-23. doi: 10.1039/c3dt50176k.

PMID:
23546021
48.

FcRγ promotes T cell apoptosis in Fas-deficient mice.

Juvet SC, Thomson CW, Kim EY, Joe B, Adeyi O, Zhang L.

J Autoimmun. 2013 May;42:80-93. doi: 10.1016/j.jaut.2012.12.002. Epub 2013 Jan 10.

PMID:
23313147
49.

Abernethy malformation type II with nephrotic syndrome and other multisystemic presentation: an illustrative case for understanding pathogenesis of extrahepatic complication of congenital portosystemic shunt.

Schaeffer DF, Laiq S, Jang HJ, John R, Adeyi OA.

Hum Pathol. 2013 Mar;44(3):432-7. doi: 10.1016/j.humpath.2012.08.018. Epub 2012 Dec 13.

PMID:
23245671
50.

Autocrine IFNγ controls the regulatory function of lymphoproliferative double negative T cells.

Juvet SC, Han M, Vanama R, Joe B, Kim EY, Zhao FL, Jeon C, Adeyi O, Zhang L.

PLoS One. 2012;7(10):e47732. doi: 10.1371/journal.pone.0047732. Epub 2012 Oct 15.

Supplemental Content

Support Center